Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial
出版年份 2021 全文链接
标题
Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial
作者
关键词
Adverse effects, Dissociation, Esketamine, Ketamine, Treatment-resistant depression
出版物
JOURNAL OF PSYCHIATRIC RESEARCH
Volume 138, Issue -, Pages 576-583
出版商
Elsevier BV
发表日期
2021-05-08
DOI
10.1016/j.jpsychires.2021.05.014
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Intravenous arketamine for treatment-resistant depression: open-label pilot study
- (2020) Gustavo C. Leal et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- The identification, assessment and management of difficult-to-treat depression: An international consensus statement
- (2020) R.H. McAllister-Williams et al. JOURNAL OF AFFECTIVE DISORDERS
- The Relationship Between Dissociation and Symptoms of Psychosis: A Meta-analysis
- (2020) Eleanor Longden et al. SCHIZOPHRENIA BULLETIN
- Can ‘Floating’ Predict Treatment Response to Ketamine? Data from Three Randomized Trials of Individuals with Treatment-Resistant Depression
- (2020) Elia E. Acevedo-Diaz et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Dissociation in relation to other mental health conditions: An exploration using network analysis
- (2020) Emma Černis et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class
- (2019) Jean Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
- (2019) Fernanda S. Correia-Melo et al. JOURNAL OF AFFECTIVE DISORDERS
- Neurobiological research with suicidal participants: A framework for investigators
- (2019) Elizabeth D. Ballard et al. GENERAL HOSPITAL PSYCHIATRY
- Dissociation in Psychiatric Disorders: A Meta-Analysis of Studies Using the Dissociative Experiences Scale
- (2018) Lisa Lyssenko et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy of Esketamine in the Treatment of Depression With Psychotic Features: A Case Series
- (2018) Elias Ajub et al. BIOLOGICAL PSYCHIATRY
- Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression
- (2018) Mark J. Niciu et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy of esketamine in the treatment of negative symptoms in schizophrenia – A case series
- (2018) Marcel V. Nunes et al. SCHIZOPHRENIA RESEARCH
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion
- (2017) Steven J. Pennybaker et al. JOURNAL OF AFFECTIVE DISORDERS
- Effect of ketamine dose on self-rated dissociation in patients with treatment refractory anxiety disorders
- (2017) Cameron Castle et al. JOURNAL OF PSYCHOPHARMACOLOGY
- S-(+)-ketamine-induced dissociative symptoms as a traumatic experience in patients with treatment-resistant depression
- (2017) Fernanda S. Correia-Melo et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- A review of the relation between dissociation, memory, executive functioning and social cognition in military members and civilians with neuropsychiatric conditions
- (2016) Margaret C. McKinnon et al. NEUROPSYCHOLOGIA
- Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review
- (2016) Matthew D. Cooper et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Concomitant Benzodiazepine Use Attenuates Ketamine Response
- (2015) Mark A. Frye et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- MDMA, cannabis, and cocaine produce acute dissociative symptoms
- (2015) Dalena van Heugten-Van der Kloet et al. PSYCHIATRY RESEARCH
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Do the dissociative side effects of ketamine mediate its antidepressant effects?
- (2014) David A. Luckenbaugh et al. JOURNAL OF AFFECTIVE DISORDERS
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
- (2013) Ji-chun Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Predictors of trait dissociation and peritraumatic dissociation induced via cold pressor
- (2013) Lydia Gómez-Pérez et al. PSYCHIATRY RESEARCH
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- A Multidimensional Tool to Quantify Treatment Resistance in Depression
- (2009) Abebaw Fekadu et al. JOURNAL OF CLINICAL PSYCHIATRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started